How did EDIT's Q4 2024 earnings surprise investors?
4/10/2025 08:45pm
Editas Medicine (EDIT) reported an earnings per share (EPS) surprise of -$0.02 for Q4 2024, which indicates that the company's actual performance fell short of market expectations. This negative surprise could have disappointed investors, potentially leading to a negative reaction in the stock price.